Poorer outcomes in patients with pulmonary hypertension in COPD - dofaq.co
Poorer outcomes in patients with pulmonary hypertension in COPD
Healio - 24 Sep 2021
Patients with pulmonary hypertension in COPD had worse clinical status and poorer outcomes compared with those with idiopathic pulmonary artery hypertension ...
MACC1 seen as biomarker for PAH in bioinformatics study
Pulmonary Hypertension News - 24 Apr 2024
MACC1 seen as biomarker for PAH in bioinformatics study ...
Her PAH Symptoms Were Getting Worse. Then She Joined a Clinical Trial
Healthline - 15 Apr 2024
Her PAH Symptoms Were Getting Worse. Then She Joined a Clinical Trial ...
Polycyclic aromatic hydrocarbon (PAH) source identification and a maternal transfer case study in threatened killer ...
Nature.com - 19 Dec 2023
Polycyclic aromatic hydrocarbon (PAH) source identification and a maternal transfer case study in threatened killer ... ...
Merck aims to 'outnumber' pulmonary arterial hypertension
FiercePharma - 16 Apr 2024
Merck aims to 'outnumber' pulmonary arterial hypertension ...
Ottawa school teacher living with rare Pulmonary Arterial Hypertension for more than a decade
CTV News Ottawa - 23 Nov 2023
Ottawa school teacher living with rare Pulmonary Arterial Hypertension for more than a decade ...
Winrevair Gains Approval For Pulmonary Arterial Hypertension, But High Price Could Limit Uptake
Forbes - 02 Apr 2024
Winrevair Gains Approval For Pulmonary Arterial Hypertension, But High Price Could Limit Uptake ...
Sources, spatial-distributions and fluxes of PAH-contaminated dusts in the Athabasca oil sands region
ScienceDirect.com - 19 Nov 2023
Sources, spatial-distributions and fluxes of PAH-contaminated dusts in the Athabasca oil sands region ...
FDA Approves Merck's WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial ...
Merck - 26 Mar 2024
FDA Approves Merck's WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial ... ...
Eureka mom becomes advocate for rare lung condition
Spectrum News - 22 Apr 2024
Eureka mom becomes advocate for rare lung condition ...
An ActRIIA fusion protein got FDA approved for PAH treatment
News-Medical.Net - 28 Mar 2024
An ActRIIA fusion protein got FDA approved for PAH treatment ...
Idiopathic Pulmonary Arterial Hypertension Workup: Approach Considerations, Imaging Studies, Cardiac Catheterization
Medscape Reference - 01 Apr 2024
Idiopathic Pulmonary Arterial Hypertension Workup: Approach Considerations, Imaging Studies, Cardiac Catheterization ...
Treating pulmonary hypertension
Boston Children's Discoveries - 26 Jan 2024
Treating pulmonary hypertension ...
Toxic chemicals found in oil spills and wildfire smoke detected in killer whales
UBC News - 19 Dec 2023
Toxic chemicals found in oil spills and wildfire smoke detected in killer whales ...
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension
Nature.com - 06 Jan 2024
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension ...
Exercise improves systemic metabolism in a monocrotaline model of pulmonary hypertension
ScienceDirect.com - 08 Mar 2024
Exercise improves systemic metabolism in a monocrotaline model of pulmonary hypertension ...
Sotatercept Tied to Disease Modification in PAH
Medscape - 15 Sep 2023
Sotatercept Tied to Disease Modification in PAH ...
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension | Scientific Reports
Nature.com - 18 Dec 2023
Transcriptional profiles of pulmonary artery endothelial cells in pulmonary hypertension | Scientific Reports ...
FDA OKs First-in-Class Sotatercept for PAH
Medscape - 27 Mar 2024
FDA OKs First-in-Class Sotatercept for PAH ...
Source analysis and health risk assessment of polycyclic aromatic hydrocarbon (PAHs) in total suspended particulate ...
Nature.com - 01 Mar 2024
Source analysis and health risk assessment of polycyclic aromatic hydrocarbon (PAHs) in total suspended particulate ... ...